Published in Epilepsia on February 01, 1981
Early prognosis of epilepsy. Br Med J (Clin Res Ed) (1982) 2.30
Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br Med J (Clin Res Ed) (1983) 1.98
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry (1985) 1.51
Medical assessment and treatment of chronic epilepsy. BMJ (1991) 1.42
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry (1995) 1.24
Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol (2009) 1.13
A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry (1994) 1.11
A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry (1982) 1.09
Two antiepileptic drugs for intractable epilepsy with complex-partial seizures. J Neurol Neurosurg Psychiatry (1982) 1.01
Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry (1983) 0.98
Chronic toxicity in epileptic patients receiving single-drug treatment. Br Med J (Clin Res Ed) (1982) 0.97
Presurgical evaluation and surgical treatment of medically refractory epilepsy. Neurosurg Rev (2003) 0.96
Quality of life in patients with epilepsy in India. J Neurosci Rural Pract (2011) 0.94
Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. J Neurol Neurosurg Psychiatry (1982) 0.90
Modern treatment strategies for patients with epilepsy: a review. J R Soc Med (1991) 0.87
Treating epilepsy: one drug or several. Can Med Assoc J (1982) 0.83
An integrative view of mechanisms underlying generalized spike-and-wave epileptic seizures and its implication on optimal therapeutic treatments. PLoS One (2011) 0.81
Drug treatment of Parkinson's disease: is "polypharmacy" best? J Neurol Neurosurg Psychiatry (1994) 0.80
Rational Polytherapy with Antiepileptic Drugs. Pharmaceuticals (Basel) (2010) 0.77
Disposition of anticonvulsants in childhood. Clin Pharmacokinet (1989) 0.77
Treating refractory epilepsy in adults. BMJ (2006) 0.76
Treatment of epilepsy in China: Formal or informal. Neural Regen Res (2013) 0.75
Treatment of epilepsy: whose right is it anyway? Br Med J (Clin Res Ed) (1982) 0.75
Postsurgical treatment of epilepsy. Epilepsy Curr (2005) 0.75
Neurology-important advances in clinical medicine: initiation of anticonvulsant therapy. West J Med (1982) 0.75
New drugs for epilepsy: a review. Can Fam Physician (1983) 0.75
Prospects for new drug treatment in epilepsy: a review. J R Soc Med (1990) 0.75
Simultaneous triple therapy for the treatment of status epilepticus. Neurobiol Dis (2017) 0.75
One drug for epilepsy. Br Med J (1978) 4.87
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain (2000) 4.76
One drug (phenytoin) in the treatment of epilepsy. Lancet (1976) 4.32
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Hippocampal sclerosis in epilepsy and childhood febrile seizures. Lancet (1993) 3.71
Chronic antiepileptic toxicity: a review. Epilepsia (1975) 3.70
Reduction in polypharmacy for epilepsy. Br Med J (1979) 3.56
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Epileptic seizures in a population of 6000. I: Demography, diagnosis and classification, and role of the hospital services. Br Med J (Clin Res Ed) (1983) 2.95
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry (1995) 2.84
Enhancement of recovery from psychiatric illness by methylfolate. Lancet (1990) 2.73
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Drug treatment of epilepsy. Lancet (1978) 2.63
Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry (1996) 2.62
Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry (2000) 2.53
Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. Lancet (1967) 2.42
Anticonvulsant drugs and mental symptoms: a review. Psychol Med (1976) 2.39
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group) Lancet (1991) 2.36
Papilloedema and the Landry-Guillain-Barré syndrome. Case reports and a review. Brain (1966) 2.32
Early prognosis of epilepsy. Br Med J (Clin Res Ed) (1982) 2.30
Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain (1992) 2.29
Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry (1987) 2.25
National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet (1990) 2.22
Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry (1976) 2.18
The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia (1995) 2.12
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br Med J (Clin Res Ed) (1983) 1.98
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain (1992) 1.94
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry (1996) 1.89
The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry (1984) 1.85
Neurological aspects of folate and vitamin B12 metabolism. Clin Haematol (1976) 1.79
Folate deficiency in depressive illness. Br J Psychiatry (1970) 1.79
Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology (1994) 1.74
Why does epilepsy become intractable? Prevention of chronic epilepsy. Lancet (1983) 1.72
Reversible absorptive defects in anticonvulsant megaloblastic anaemia. J Clin Pathol (1965) 1.68
Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry (1993) 1.64
Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol (1995) 1.64
Multiple sclerosis and macrocytosis. Acta Neurol Scand (1990) 1.64
Anticonvulsant therapy, folic acid and vitamin B12 metabolism and mental symptoms. Epilepsia (1966) 1.62
Early treatment and prognosis of epilepsy. Epilepsia (1987) 1.60
Presurgical evaluation of patients with epilepsy and normal MRI: role of scalp video-EEG telemetry. J Neurol Neurosurg Psychiatry (1999) 1.59
The switch mechanism and the bipolar/unipolar dichotomy. Br J Psychiatry (1989) 1.58
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry (1995) 1.58
A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage (2003) 1.58
The neuropsychiatry of megaloblastic anaemia. Br Med J (1980) 1.56
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol (2001) 1.56
Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report. Br J Psychiatry (1974) 1.51
Vigabatrin and behaviour disturbance. Lancet (1990) 1.50
Water intoxication due to carbamazepine. Br Med J (1977) 1.48
Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. J Neurol Neurosurg Psychiatry (1990) 1.48
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? Mov Disord (1992) 1.47
The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med (1984) 1.46
Multiple sclerosis and macrocytosis. Lancet (1989) 1.46
National general practice study of epilepsy: the social and psychological effects of a recent diagnosis of epilepsy. BMJ (1992) 1.45
The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res (1994) 1.44
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet (1996) 1.41
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain (1996) 1.38
Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain (2001) 1.37
An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Brain (1996) 1.36
Prognosis after a first untreated tonic-clonic seizure. Lancet (1985) 1.33
Vitamin B12 deficiency, demyelination, and multiple sclerosis. Lancet (1987) 1.32
Mental effects of anticonvulsants, and folic acid metabolism. Brain (1968) 1.31
The nature of epilepsy in the general population. I. Characteristics of patients receiving medication for epilepsy. Epilepsy Res (1995) 1.31
The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res (1990) 1.30
Folate status in a geriatric population and its relation to dementia. Age Ageing (1973) 1.27
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry (1995) 1.24
Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia (1995) 1.24
Texts and documents. Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy. Med Hist (1990) 1.24
Iatrogenic disorders in epilepsy. Mod Trends Neurol (1970) 1.23
Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain (1992) 1.22
Neurological disease associated with folate deficiency. Br Med J (1973) 1.22
Variation in response to anticonvulsants in a group of epileptic patients. Arch Neurol (1972) 1.21
Circumstances of death in sudden death in epilepsy: interviews of bereaved relatives. J Neurol Neurosurg Psychiatry (1998) 1.21
Serum levels of anticonvulsant drugs. Interpretation and clinical value. Pharmacol Ther (1980) 1.21
Anticonvulsants, folic acid, and epilepsy. Lancet (1973) 1.20
Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure (2004) 1.19
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry (1990) 1.17
The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs (1994) 1.17
Mental effects of antiepileptic medication: a review. Epilepsia (1983) 1.16
The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol (1992) 1.16
The nature of epilepsy in the general population. II. Medical care. Epilepsy Res (1995) 1.16
Folates and psychiatric disorders. Clinical potential. Drugs (1993) 1.15
National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology (1992) 1.15
Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology (1995) 1.14
Subacute combined system degeneration with folate deficiency. JAMA (1972) 1.14
Methylation and mood. Lancet (1984) 1.14
Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia (1997) 1.14
Neuropathy and myopathy in two patients with anorexia and bulimia nervosa. J Neurol Neurosurg Psychiatry (1985) 1.12
Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology (1995) 1.12